Bio-Techne Stock Price. Everything You Need To Know About The Bio-Techne Stock!
Headquartered in Minneapolis, Minnesota, Bio-Techne Corp. is a leading developer, manufacturer, and seller of biotechnology reagents and instruments for the research and clinical diagnostic markets. With 3,000 full-time employees, the firm operates through two segments – Protein Sciences and Diagnostics and Genomics.
The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics, and cell and gene therapy. It also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflows.
The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market. It also offers exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.
Investors who want to keep up with Bio-Techne Corp.’s performance in the stock market can track the stock price today, including any premarket fluctuations. The company’s shares and market cap are key indicators of its financial health. With its strong presence in the biotechnology industry and diverse product offerings, Bio-Techne Corp. remains a top player in the market.
Bio-Techne Stock Price. Everything You Need To Know About The Bio-Techne Stock! performance
- Employees 3000
- Company HQ Minneapolis
- Website https://www.bio-techne.com/
- TECH Asset Type Common Stock
- TECH Market Capitalization 9.9B
- Earnings Per Share 1.39
- Dividends Per Share 0.32
- Dividend Date 2024-02-26
- Quarterly Earnings Growth -0.452
Are you interested in investing in the promising field of biotechnology? Look no further than Bio-Techne, a leading global provider of innovative life science products and services. As a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, you can now seize the opportunity to invest in this dynamic stock through Zorion’s investment platform. Bio-Techne is revolutionizing the biotech industry with its diverse portfolio of cutting-edge products and solutions. From advanced proteins and antibodies to high-quality genomic tools, Bio-Techne empowers researchers and scientists worldwide. But how can you invest in Bio-Techne from Malaysia, Thailand, Indonesia, or Vietnam? Zorion’s user-friendly platform provides seamless access to real US stocks, including Bio-Techne. By utilizing Zorion’s investment insights and recommendations, you can make informed decisions and maximize your potential gains. Additionally, Zorion offers a wealth of educational resources to help you enhance your investment knowledge. Whether you’re a seasoned investor or just beginning your investment journey, Zorion equips you with the necessary tools to navigate the stock market confidently. Investing in Bio-Techne is a strategic move that allows you to be part of the biotech revolution. With Zorion’s support and guidance, you can unlock the potential for significant returns while diversifying your investment portfolio. Take the first step towards a brighter financial future by investing in Bio-Techne today!
